Results 91 to 100 of about 4,568 (194)

Targeting Immune-Mediated Responses to Tackle GNE Myopathy [PDF]

open access: gold, 2022
Mariana Barbosa   +2 more
openalex   +1 more source

Supplemental Figure 4 from Combination Drug Scheduling Defines a “Window of Opportunity” for Chemopotentiation of Gemcitabine by an Orally Bioavailable, Selective ChK1 Inhibitor, GNE-900

open access: gold, 2023
Elizabeth Blackwood   +19 more
openalex   +1 more source

BRD4 PROTAC Degradation Agent GNE-987 Inhibits Acute Myeloid Leukemia by Targeting Super Enhancers [PDF]

open access: green, 2021
Xu Sang   +22 more
openalex   +1 more source

Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer

open access: green, 2021
Jennifer E. Klomp   +31 more
openalex   +1 more source

GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)

open access: green, 2017
Terry D. Crawford   +33 more
openalex   +2 more sources

Genetics of GNE myopathy in the non-Jewish Persian population [PDF]

open access: bronze, 2015
Alireza Haghighi   +8 more
openalex   +1 more source

Distributed Charging Strategy of PEVs in SCS with Feeder Constraints Based on Generalized Nash Equilibria

open access: yesAxioms
In this article, a distributed charging strategy problem for plug-in electric vehicles (PEVs) with feeder constraints based on generalized Nash equilibria (GNE) in a novel smart charging station (SCS) is investigated.
Jialong Tang   +5 more
doaj   +1 more source

Novel Pathogenic Variants in a French Cohort Widen the Mutational Spectrum of GNE Myopathy

open access: hybrid, 2015
Mathieu Cérino   +9 more
openalex   +2 more sources

Ion Mobility QTOF-MS Untargeted Lipidomics of Human Serum Reveals a Metabolic Fingerprint for GNE Myopathy [PDF]

open access: gold
Cristina Manis   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy